Accuracy of routine fat-suppressed FLAIR and diffusion-weighted images in detecting clinically evident acute optic neuritis.

BACKGROUND Contrast-enhanced, fat-suppressed T1-weighted imaging (CET1WI) magnetic resonance imaging (MRI) is quite sensitive in detecting acute optic neuritis (ON), but ON remains a clinical diagnosis. MRI is indicated to evaluate demyelinating brain lesions rather than the optic nerves, while "routine" brain protocols typically include axial FLAIR and DWI. PURPOSE To evaluate the accuracy of axial, fat-suppressed FLAIR and DWI sequences used for our routine brain imaging in detecting acute ON, as compared to CET1WI and the clinical diagnosis. MATERIAL AND METHODS The clinical data and MRI examinations were retrospectively reviewed of 60 patients presenting to a neuro-ophthalmologist for various visual symptoms. Each patient underwent dedicated neuro-ophthalmologic examination, with axial 5 mm fat-suppressed FLAIR and DWI (part of "routine" brain MRI protocol), as well as 3 mm axial and coronal fat-suppressed CET1WI (part of dedicated orbit MRI protocol). Two neuroradiologists independently evaluated FLAIR and DWI, while CET1WI was reviewed by consensus. RESULTS Thirty-one patients were clinically positive, 29 negative for ON (total = 34 positive and 86 negative nerves). The sensitivities of FLAIR, DWI, and CET1WI for ON were 75.7-77.3%, 77.3%, and 89.5%, respectively; the specificities were 90.5-93.5%, 80.4-82.7%, and 86.0%, respectively; the accuracies were 85.7-88.2%, 79.5-81.1%, and 87.0%, respectively. Inter-observer kappa was 0.783 for FLAIR, and 0.605 for DWI; intra-observer kappa was 0.746-0.816 for FLAIR, and 0.674-0.699 for DWI (each P < 0.0001). CONCLUSION Being more specific, but not as sensitive, as dedicated CET1WI in acute ON, axial fat-suppressed FLAIR likely has additional value in evaluating for acute ON in "routine" brain MR protocols evaluating for demyelinating disease, while DWI may be hampered by artifacts.

[1]  U. Motosugi,et al.  Diffusion-Weighted Imaging in Optic Neuritis , 2013, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[2]  P. Mukherjee,et al.  MR Imaging of Optic Neuropathy with Extended Echo-Train Acquisition Fluid-Attenuated Inversion Recovery , 2011, American Journal of Neuroradiology.

[3]  G. Plant,et al.  Optic neuritis: a review. , 2009, International MS journal.

[4]  N. Volpe,et al.  Optic neuritis and risk of MS: Differential diagnosis and management , 2009, Cleveland Clinic Journal of Medicine.

[5]  Nikolaus Weiskopf,et al.  Efficient fat suppression by slice-selection gradient reversal in twice-refocused diffusion encoding , 2008, Magnetic resonance in medicine.

[6]  Melvin Greer,et al.  Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. , 2008, Archives of neurology.

[7]  E. Rostrup,et al.  Magnetic Resonance Imaging at 3.0 Tesla Detects More Lesions in Acute Optic Neuritis Than at 1.5 Tesla , 2006, Investigative radiology.

[8]  M. Brodsky,et al.  Neurologic impairment 10 years after optic neuritis. , 2004, Archives of neurology.

[9]  Stephen J. Jones,et al.  Optic nerve diffusion measurement from diffusion-weighted imaging in optic neuritis. , 2004, AJNR. American journal of neuroradiology.

[10]  L. Levin,et al.  Risk of multiple sclerosis after optic neuritis. , 2003, JAMA.

[11]  L. Levin,et al.  Optic neuritis and multiple sclerosis. , 2003, Archives of ophthalmology.

[12]  Michael Wall,et al.  High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2003, Archives of ophthalmology.

[13]  D. Miller,et al.  Management of acute optic neuritis , 2002, The Lancet.

[14]  M. Kupersmith,et al.  Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. , 2002, Brain : a journal of neurology.

[15]  David H. Miller,et al.  ADC mapping of the human optic nerve: Increased resolution, coverage, and reliability with CSF‐suppressed ZOOM‐EPI , 2002, Magnetic resonance in medicine.

[16]  G. T. Plant,et al.  Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence , 2001, Neuroradiology.

[17]  M. Lowe,et al.  Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. , 1999, Radiology.

[18]  T. Iwasawa,et al.  Diffusion‐weighted imaging of the human optic nerve: A New approach to evaluate optic neuritis in multiple sclerosis , 1997, Magnetic resonance in medicine.

[19]  L. Kurland,et al.  Optic neuritis , 1995, Neurology.

[20]  J. Guy,et al.  Intraorbital optic nerve and experimental optic neuritis. Correlation of fat suppression magnetic resonance imaging and electron microscopy. , 1992, Ophthalmology.

[21]  W. D. Bidgood,et al.  Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging. , 1992, Ophthalmology.

[22]  Neil R. Miller,et al.  A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis , 1992 .

[23]  B E Kendall,et al.  The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. , 1991, Brain : a journal of neurology.

[24]  F. Murtagh,et al.  Contrast-enhanced MR imaging of optic nerve lesions in patients with acute optic neuritis. , 1991, AJNR. American journal of neuroradiology.

[25]  J. Hesselink,et al.  MR fat suppression combined with Gd-DTPA enhancement in optic neuritis and perineuritis. , 1991, Journal of computer assisted tomography.

[26]  J. Hesselink,et al.  Intra- and paraorbital lesions: value of fat-suppression MR imaging with paramagnetic contrast enhancement. , 1991, AJNR. American journal of neuroradiology.

[27]  R. Beck The Optic Neuritis Treatment Trial. , 1988, Archives of ophthalmology.

[28]  Jacob Cohen A Coefficient of Agreement for Nominal Scales , 1960 .

[29]  R. Sergott,et al.  Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. , 2008, Ophthalmology.

[30]  M. Brodsky,et al.  Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2004, American journal of ophthalmology.

[31]  A. Jackson,et al.  Optic neuritis: MR imaging with combined fat- and water-suppression techniques. , 1998, Radiology.

[32]  J L Keltner,et al.  A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. , 1992, The New England journal of medicine.